| Value | ₹7.08 Cr |
|---|
BSE filing, NSE: ASTRAZEN. Summary written from the filing by ALFA Finder's alert engine.
AstraZeneca Pharma India Ltd: key numbers
- Share price
- ₹6,294.00
- Market cap
- ₹15,735 Cr
- Revenue (annual)
- ₹2,276 Cr
- Net profit (annual)
- ₹187.5 Cr
- P/E (TTM)
- 92.8×Sector 42.0×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 2.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from AstraZeneca Pharma India Ltd
All →AstraZeneca Pharma India Results Update
AstraZeneca Pharma India reported 30% growth in Q2 results, with three new regulatory approvals. It also announced MoUs with two state governments.
AstraZeneca Pharma India Q2 FY27 Results: Net Profit ₹62.3 Cr, Up 14.9% YoY
AstraZeneca Pharma India Ltd reported revenue from operations of ₹729.1 Cr (+30.4% YoY) and net profit of ₹62.3 Cr (+14.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹62.3 Cr · +14.9% YoY
AstraZeneca Pharma India Legal & Regulatory
Delhi High Court directed NPPA to refrain from coercive steps on Rs.151.20 Crore alleged Symbicort Turbuhaler overcharging. Next hearing is January 11, 2027.
- Value
- ₹151.2 Cr
AstraZeneca Pharma India Other Announcement
AstraZeneca Pharma India filed its quarterly shareholding pattern for the period ended 30 September 2026. Promoter and promoter group hold 75% of total equity.
AstraZeneca Pharma India Board Meeting Date
AstraZeneca Pharma India scheduled its board meeting for 5 Nov 2026 to approve Q2/H1 FY27 results. The trading window remains closed until 7 Nov 2026.
AstraZeneca Pharma India Capacity Expansion
AstraZeneca Pharma India inaugurated a new corporate office in Mumbai, covering 25,600 sq ft. This expansion strengthens the company's commercial operations and footprint in India.
- office space
- 25600.0 sq ft
Other legal & regulatory announcements
All →TCI Express Legal & Regulatory
TCI Express disclosed a ₹62.01 crore claim by Edutest Solutions in the Delhi High Court. The company disputes it and sees no material financial impact.
- Value
- ₹62.01 Cr
Jay Ambe Supermarkets Legal & Regulatory
Jay Ambe Supermarkets filed Form ADJ with MCA against ROC penalty orders under the Companies Act. Filing was made within the prescribed period.
Gala Precision Engineering Legal & Regulatory
Gala Precision reported a Code of Conduct violation under PIT Regulations by Designated Person Madhu Ashar, who made a contra trade. The Audit Committee issued a warning and a Rs 5,000 penalty.
- Value
- ₹0.00 Cr
Swastika Investmart Legal & Regulatory
Swastika Investmart disclosed a SEBI adjudication order imposing a Rs. 10 lakh penalty under Section 15HB for merchant banking non-compliances. The company plans to seek settlement, with no other material impact.
- Value
- ₹0.10 Cr
GHV Infra Projects Legal & Regulatory
GHV Infra's UAE subsidiary obtained emergency arbitral relief staying Rana Exim's guarantee invocation. Disputed EMD claim of about ₹28.11 Crore remains before the tribunal.
- Value
- ₹28.11 Cr
Span Divergent Legal & Regulatory
Span Divergent received a partly favourable CIT(Appeals) order for AY 2018-19 deleting a ₹1,57,500 Section 69C addition. The order is a tax matter with no business impact stated.
- Value
- ₹0.02 Cr